ICR scientists study cancer response to new class of drugs
The research could help determine drug responses through genetic testing
Read More
Tag: ICR London
ICR’s new study tracks disease progression in children with rare type of cancer
Researchers assessed whether measuring DNA shed by cancer cells into the bloodstream could track tumour progression
Read More
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
